德国制药和农化集团拜耳首席执行官比尔·安德森周二表示，公司预计其Roundup除草剂72.5亿美元的和解将在圣诞节前达成。
German drugs and agrochemicals group Bayer is expecting a $7.25 billion settlement on its Roundup weedkiller to come before Christmas, CEO Bill Anderson said on Tuesday.
该公司正寻求通过拟议的和解解决数万起Roundup诉讼，该和解目前正由密苏里州圣路易斯的一名州法院法官审查。
The company is seeking to resolve tens of thousands of Roundup lawsuits through the proposed settlement, which is under review by a Missouri state court judge in St. Louis.
安德森在公司发布业绩后的新闻电话会上表示：“可能任何一周都会达成”，并补充说和解后将只剩下少得多的个别案件。
"It could be any week now," Anderson said in a press call following the company's results, adding there would be a much smaller number of individual cases after the settlement.
拜耳在美国州法院和联邦法院面临约6.5万起索赔，原告称他们在家庭或工作中使用Roundup后患上了非霍奇金淋巴瘤和其他形式的癌症。
Bayer is facing approximately 65,000 claims in US state and federal courts from plaintiffs who say they developed non-Hodgkin lymphoma and other forms of cancer after using Roundup at home or on the job.
在6月取得最高法院胜利后，拜耳将其美国Roundup业务移入一个名为Ruveon的部门，并在内部将其与组织其他部分分离。
Following a Supreme Court victory in June, Bayer moved its US Roundup business into a unit dubbed Ruveon and internally separated it from the rest of the organisation.
拜耳表示，数十年的研究表明，Roundup的活性成分草甘膦是安全的，不会致癌。
Bayer has said that decades of studies have shown glyphosate, Roundup's active ingredient, is safe and does not cause cancer.